Fred Schwarzer, IGM Biosciences CEO
As shares skyrocket on Sanofi deal, IGM Biosciences looks to bag $200M
IGM Biosciences didn’t skip a beat capitalizing on all the new love pouring in for its stock. Just hours after unveiling a deal with Sanofi …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
